University Hospital Ventures

What University Hospital Ventures does

University Hospital Ventures is the innovation and commercialization division of University Hospitals Health System, a private nonprofit integrated health system founded in 1866 and headquartered in Cleveland, Ohio. UH Ventures operates as a corporate venture arm rather than a standalone product company, deploying capital and operational support through three primary vehicles: the Feuer Innovation Accelerator (a $2 million internal fund established in 2021 from a gift by Michael and Ellen Feuer, controlled at UH CEO discretion); the Healthcare Collaboration Fund (co-managed with JumpStart Ventures for pre-seed investments in Northeast Ohio healthcare startups); and a curated portfolio of more than 20 portfolio companies spanning medical devices, digital health, therapeutics, and imaging. The division formalizes stakeholder engagement through four Innovation Pathways — UH Caregivers (internal innovators), Healthcare Startups, Industry Partners, and Investors — and applies a proprietary human-centered design methodology organized as Gather Data, Grasp Insights, Give it Life.

Underlying platform capabilities include the UH Haslam Sports Innovation Center and the SportsLand event platform (sports technology and human performance), the RadiCLE Radiology AI & Diagnostic Innovation Collaborative (international radiology AI validation — the only U.S. healthcare system partner of AZmed, whose Rayvolve algorithm received FDA clearance), the Health Voyagers podcast series, and structured IP pipelines generating FDA-cleared devices such as the Relief Urinary Stent (Dr. Lee Ponsky), the ArthroFree Wireless Arthroscopic Camera (Lazurite with UH Ventures collaboration), the NeuRx Diaphragm Pacing System (Dr. Raymond Onders), and the FORGE Minimally Invasive Glaucoma Stent (Dr. Faruk H. Orge).

The business model combines grant capture (e.g., $500,000 from Ohio Third Frontier's Technology Validation & Startup Fund plus $300,000 to portfolio companies RightFlow Medical and Hemaptics), direct equity investments and co-investments (e.g., co-investor in Axuall's $10.4M Series A; investor in Lazurite, TailorMed, STAQ PHARMA, Renalis, Augment Therapy), licensing/royalty streams on internally developed IP, and ad hoc accelerator programming. Pricing is not publicly disclosed; investment amounts and partnership terms are negotiated individually. Revenue is consolidated into the parent University Hospitals Health System and is not separately reported, but measurable clinical and operational outcomes (45% faster OR assembly, 23% faster disassembly for ArthroFree; 5.6% higher fracture detection accuracy; 27% faster X-ray interpretation; less than 5% of approached startups contracted annually) indicate the operating thesis is rigorous validation in exchange for clinical and equity participation.

Name

University Hospital Ventures

Legal name

University Hospitals Ventures

Website

https://ventures.uhhospitals.org

Company type

Private

Founded year

1866

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

University Hospital Ventures is the innovation and commercialization division of University Hospitals Health System in Cleveland, deploying investment funds, accelerators, and clinical-validation platforms to commercialize healthcare innovations across medical devices, digital health, therapeutics, and AI.

Ownership category

akta.pro rank

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Venture Investment Returns: UH Ventures invests in healthcare companies and UH spin-outs, drawing on University Hospitals' clinical, operational, and innovator insights to identify promising opportunities. Returns generated through equity appreciation, exits, and commercialization of innovations.
2. Healthcare Collaboration Fund: Co-managed fund with JumpStart Ventures focused on pre-seed investments in Northeast Ohio technology startups in biomedical, life sciences, diagnostics, imaging, surgical instruments, therapeutics, and healthcare software.
3. Grant Funding: Secured grant funding from Ohio Third Frontier (TVSF) to advance early-stage ideas, validate technologies, and support innovation development. UH Ventures matched with $500,000 for total of $1M deployment.
4. Feuer Innovation Accelerator: $2 million gift from Michael and Ellen Feuer established accelerator fund at UH for promising ideas with highest potential impact on healthcare delivery and research, used at CEO discretion for agile decision-making.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

UH Ventures is the innovation and commercialization division of University Hospitals Health System. It identifies, develops, validates, and commercializes disruptive healthcare innovations through venture investment, accelerator funding, and clinical validation support. Core offerings include the Healthcare Collaboration Fund (pre-seed Ohio healthcare startups co-managed with JumpStart Ventures), the Feuer Innovation Accelerator ($2M internal innovation fund), structured Innovation Pathways for caregivers, startups, industry partners and investors, the RadiCLE AI validation collaborative, and licensing/commercialization of internally invented medical devices.

Product overview

UH Ventures operates as the innovation and commercialization division of University Hospitals Health System. The organization does not offer a single unified product but rather provides a portfolio of programs and investment vehicles including the Healthcare Collaboration Fund (co-managed with JumpStart for pre-seed Ohio companies), the Feuer Innovation Accelerator (a $2 million fund for promising UH ideas), and Innovation Pathways for different stakeholder groups (UH Caregivers, Healthcare Startups, Industry Partners, Investors). UH Ventures also facilitates the SportsLand platform and produces the Health Voyagers Podcast Series. The organization supports a diverse portfolio of portfolio companies spanning medical devices, digital health, therapeutics, and healthcare technology, as well as internal innovation projects developed by UH caregivers.

Differentiator

Problem solved

Functional benefit

Brands

• Healthcare Collaboration Fund: A fund co-managed with JumpStart Ventures that targets investments in Northeast Ohio technology startup companies primarily in biomedical and life sciences related to diagnostics, imaging, surgical instruments and equipment, implant devices, therapeutics, and regenerative medicine, as well as software applications for healthcare
• UH Haslam Sports Innovation Center
• Feuer Accelerator
• RadiCLE (Radiology AI & Diagnostic Innovation Collaborative)

Products and services

• Healthcare Collaboration Fund A co-managed investment fund with JumpStart Ventures that targets pre-seed investments in Northeast Ohio technology startup companies primarily in biomedical and life sciences, including diagnostics, imaging, surgical instruments, implant devices, therapeutics, regenerative medicine, and healthcare software applications. Designed to provide venture capital support to early-stage healthcare startups.
• Feuer Innovation Accelerator A $2 million accelerator fund established through a gift from Michael and Ellen Feuer that advances promising healthcare ideas from ideation through market assessment and prototype development, with deployment decisions made at the discretion of the UH CEO. Targeted at UH caregivers and internal innovators.
• Innovation Pathways Program Structured engagement pathways for different stakeholder groups including UH Caregiver (internal innovators), Healthcare Startups, Industry Partners, and Investors. Each pathway provides tailored support for moving healthcare innovations through validation, commercialization, and scaling.
• RadiCLE (Radiology AI & Diagnostic Innovation Collaborative) An AI research collaborative in partnership with the University Hospitals Department of Radiology that partners with startups worldwide to validate emerging AI radiology technologies, including fracture detection algorithms (e.g., AZmed's AI Rayvolve) and stroke identification algorithms. Operates as the clinical validation component of UH Ventures' innovation work.
• SportsLand Platform A collaboration platform convened by UH Ventures, UH Haslam Sports Innovation Center, and OhioX focusing on performance nutrition, biomechanics of injury prevention, surgical technology, athlete development, and the economic impact of sports in Cleveland. Held at Huntington Bank Field.
• Health Voyagers Podcast Series A podcast series featuring conversations with healthcare innovators, entrepreneurs, and leaders discussing biomimicry, mental health, sports technology, and women's health innovation. Available on Apple Podcasts, Spotify, and SoundCloud.

Quantifiable outcome

• 45% faster assembly and 23% faster disassembly in operating room for ArthroFree wireless camera system vs traditional wired systems
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• ScriptDropcoreStrategic or Co-development Partner · 11 October 2022Pilot collaboration for prescription delivery directly to UH patients' homes using ScriptDrop's proprietary web platform and courier coverage from central fill pharmacy.
• HCA HealthcarecoreStrategic or Co-development Partner · 7 July 2022Product innovation collaboration with Vicarious Surgical Inc. to advance the design of the Vicarious Surgical Robot through Center of Excellence agreement.
• LazuritecoreStrategic or Co-development Partner · 22 February 2022Expanded collaboration including investment in the medical device company developing ArthroFree wireless surgical camera system. UH Ventures provides living laboratory for testing and validation.
• AxuallcoreStrategic or Co-development Partner · 19 May 2020Strategic collaboration to develop and test blockchain and digital credential mechanisms to reduce time for deploying qualified clinical staff. UH Ventures and Axuall began working together in 2019.
• OhioXcoreStrategic or Co-development PartnerPartnership for SportsLand event platform bringing together pioneers in medicine, professional sports, technology, venture capital and startups for conversation and collaboration. OhioX is a statewide tech nonprofit association.
• C-Path (Critical Path Institute)minorStrategic or Co-development PartnerTranslational Therapeutics Accelerator announced $200,000 grant for drug development project in inflammatory bowel disease.
• AZmedminorStrategic or Co-development PartnerFrench AI company whose AI Rayvolve fracture detection algorithm was validated through RadiCLE collaborative. UH was only U.S. healthcare system to collaborate with AZmed.
• NFL (National Football League)minorStrategic or Co-development PartnerDr. Brian Rothstein serves as Independent Neuro Consultant for NFL. UH Concussion program and sports medicine innovations support player safety.
• Cleveland CliniccoreStrategic or Co-development PartnerCollaboration during COVID pandemic to battle pandemic and boost the region. Organizations now meet 3-4 times monthly with shared mission.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Market position

Strengths4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/UH_Ventures
• LinkedInlinkedin.com/company/university-hospitals-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Hospital Ventures